223796-38-1 Usage
Chemical structure
A heterocyclic compound with a homopiperazine ring attached to a 5-phenyl-pyridin-3-yl group.
Pharmacological activities
Exhibits antipsychotic and anxiolytic properties.
Potential applications
Treatment of anxiety disorders, schizophrenia, and other psychiatric disorders.
Unique structure
The combination of a homopiperazine ring and a 5-phenyl-pyridin-3-yl group contributes to its pharmacological profile.
Research and development
Promising candidate for further research and development in the field of pharmaceutical chemistry.
Drug candidate
Its potential therapeutic effects make it a candidate for the development of new medications to treat various psychiatric disorders.
Check Digit Verification of cas no
The CAS Registry Mumber 223796-38-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,2,3,7,9 and 6 respectively; the second part has 2 digits, 3 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 223796-38:
(8*2)+(7*2)+(6*3)+(5*7)+(4*9)+(3*6)+(2*3)+(1*8)=151
151 % 10 = 1
So 223796-38-1 is a valid CAS Registry Number.
223796-38-1Relevant articles and documents
Novel potent ligands for the central nicotinic acetylcholine receptor: Synthesis, receptor binding, and 3D-QSAR analysis
Nielsen, Simon Feldb?k,Nielsen, Elsebet ?stergaard,Olsen, Gunnar M.,Liljefors, Tommy,Peters, Dan
, p. 2217 - 2226 (2000)
In the past few years the focus on central acetylcholine receptors has shifted from-compounds with affinity for muscarinic acetylcholine receptors (mAChR) to compounds with affinity for nicotinic acetylcholine receptors (nAChR). The therapeutic potential
